This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Esomeprazole
NEXIUM, NEXIUM24HR – AstraZeneca Canada Inc. (NOC Search)
Patents:
- 1264751: APOTEX, RIVA, MYLAN
- 1292693: RIVA, APOTEX, MYLAN
- 1302891: APOTEX, RIVA
- 1338377: PHARMASCIENCE, MYLAN, APOTEX, RANBAXY, RIVA
- 2133762: PHARMASCIENCE
- 2139653: MYLAN, SANDOZ, PHARMASCIENCE, APOTEX
- 2166483: MYLAN, PHARMASCIENCE, RIVA, RANBAXY, APOTEX
- 2166794: MYLAN, SANDOZ, PHARMASCIENCE, RIVA, RANBAXY, APOTEX
- 2170647: RIVA, RANBAXY, APOTEX, MYLAN, TEVA, PHARMASCIENCE
- 2180535: PHARMASCIENCE
- 2180647: RANBAXY
- 2186037: RANBAXY, RIVA, APOTEX, MYLAN, PHARMASCIENCE, TEVA
- 2193994: APOTEX
- 2226184: APOTEX
- 2274076: APOTEX, SANDOZ
- 2284470: SANDOZ
- 2290531: RIVA, RANBAXY, APOTEX, MYLAN, TEVA, PHARMASCIENCE
- 2290963: MYLAN, TEVA, PHARMASCIENCE, RIVA, RANBAXY, APOTEX
- 2346988: TEVA, PHARMASCIENCE, MYLAN, RIVA, RANBAXY
APOTEX
- Section 8 – T-389-11 (2016 FC 552)
- Appeal – A-180-11 (2011 FCA 211) – A-370-12 (2013 FCA 47) – A-420-14 (2015 FCA 158) – A-72-18 – A-92-18
- PM(NOC) – A-33-10 (2010 FCA 111) – T-138-08 – T-2-08 – T-3-08 – T-371-08 (2008 FC 1316, 2009 FC 269, 2010 FC 65, 2010 FC 714, 2011 FC 663) – T-372-08 – T-376-08 – T-378-08 – T-46-08 – T-49-08
- Infringement – T-1668-10 (2011 FC 505, 2017 FC 545, 2018 FC 181, 2018 FC 185, 2014 FC 638)
MYLAN
- PM(NOC) – T-134-10
PHARMASCIENCE
- Appeal – A-470-12 (2014 FCA 133)
- Section 8 – T-1200-15
- PM(NOC) – T-1652-10 (2012 FC 1189) – T-1653-10 – T-1654-10 – T-1677-10
RANBAXY
- PM(NOC) – A-121-13 – T-2012-10 (2013 FC 232)
RIVA
SANDOZ
- PM(NOC) – T-706-07
TEVA
- PM(NOC) – T-1856-14
Return to the Patented Medicine Litigation page.